Evaluation of pre- and postprandial growth hormone (GH)-releasing hormone-induced GH response in subjects with persistent body weight normalisation after biliopancreatic diversion

Abstract

BACKGROUND: Obesity is characterised by growth hormone (GH) abnormalities, including a blunted response to stimulation and a ‘paradoxical’ increase after meals. The blunted GH release is reversed by a surgical intestinal bypass procedure. However, this does not mean that normal GH dynamics have been restored. The present study assessed whether post-surgical weight reduction in obese patients normalised the modulation of GH release produced by metabolic fuels.

SUBJECTS: Ten obese female subjects, aged 23–54 y, were studied before and after biliopancreatic diversion (BPD). All patients, after surgery, had experienced a significant reduction in body weight (mean body mass index (BMI) 25.78±1.01 kg/m² vs 44.68±1.73 kg/m²). Two groups were also studied as controls: Ten normal body weight female subjects and ten patients suffering from anorexia nervosa (AN, mean BMI 17.46±1.12 kg/m²).

MEASUREMENTS: We have studied the GH response to a GH releasing hormone (GHRH) bolus (1 μg/kg iv, at 13.00 h) before and after a standard meal.

RESULTS: In post-BPD subjects, the GH response to GHRH in the fasting state, was clearly augmented in comparison with the pre-BPD values (peak values 18.06±4.56 vs 3.24±0.68 μg/L). In post-BPD subjects the postprandial GH response was further augmented in comparison with the fasting test (peak 30.12±4.99 μg/L, P<0.05). This pattern was similar to that observed in anorexic patients.

CONCLUSION: The surgical procedure restores a normal GH response to GHRH in the fasting state, but the ‘paradoxical’ GH response after meals remains present, suggesting a persistent GH derangement in such patients, which is not related to body weight per se. The surgical procedure makes obese patients similar to anorexics, in the relationships between metabolic fuels and GH secretion. The persistence of the GH postprandial response to GHRH in post-BPD subjects suggests a role for metabolic fuels in the regulation of somatostatin (SRIF) secretion.